ZE
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
9.51
Exchange
XCSE - Nasdaq Copenhagen A/S
-182 %
Last period ROIC
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Zealand Pharma
Company Analysis
ZEAL.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
ZEAL.CO financial analysis by Eyestock methodology
Valuation
ZEAL.CO valuation using historical relative method
Statements
ZEAL.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ZEAL.CO dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
Zealand Pharma`s ROIC for the last twelve months ended 2024-06-30 is -182 %
